Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy
/in Glioblastoma, International Publications /von 2006-09-27 / J. Neurooncol. 2007 Jan;81(2):139-48Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
/in Glioblastoma, International Publications /von 2006-09-01 / Cancer Res. 2006 Sep;66(17):8887-96Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy
/in Glioblastoma, International Publications /von 2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-50Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
/in Glioblastoma, International Publications /von 2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-31Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination
/in Glioblastoma, International Publications /von 2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):233-47Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12
/in Glioblastoma, International Publications /von 2006-02-04 / Cancer Immunol. Immunother. 2006 Nov;55(11):1309-19Novel immunotherapeutic approaches to glioma
/in Glioblastoma, International Publications /von 2006-02-01 / Curr. Opin. Mol. Ther. 2006 Feb;8(1):46-51Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
/in Glioblastoma, International Publications /von 2006-01-01 / Clin Neurosurg 2006;53:345-51Harnessing the immune system against human glioma
/in Glioblastoma, International Publications /von 2005-12-01 / Ann. N. Y. Acad. Sci. 2005 Dec;1062:13-21
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de